Company / Depreciation & Amortization
Summit Therapeutics Inc. Depreciation & Amortization History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$146.0K
FY2025
5-year range
$146.0K / $330.0K
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#158 of 168
Health Care
What the data says
Among 168 Health Care companies, Summit Therapeutics Inc. is in the top 6% for depreciation & amortization. Improved from $321,000 to $146,000 over the past 6 years.
Based on SEC 10-K filings.
$146,000 in FY2025 with a 3-year CAGR of -23.8%.
Improved from $321,000 to $146,000 over the past 6 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -23.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 6% in Health CareTop 6% of 168This company $146.0K Sector average $212.9M
▼
-99.9% below sector average
Key checks
Key Insights
- 3-year CAGR of -23.8%, indicating a declining trend.
- Ranks #158 out of 168 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $146.0K | - |
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | $330.0K | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | $321.0K | -21.5% |
| FY2018 | $409.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026